Japan· JP-1190402A1028
ナタリズマブ（遺伝子組換え）
A medicinal product containing ナタリズマブ（遺伝子組換え）, registered in Japan by バイオジェン・ジャパン, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ナタリズマブ（遺伝子組換え）
- Manufacturer
- バイオジェン・ジャパン
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ナタリズマブ（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTyrukoAbacus Medicine A/S
- CzechiaTYRUKOSandoz GmbH, Kundl
- SpainTYRUKO 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONSandoz Gmbh
- BelgiumTyruko 300 mgSandoz
- SwitzerlandTyruko 300 mg / 15 ml, Konzentrat zur Herstellung einer InfusionslösungSandoz Pharmaceuticals AG
- NetherlandsTyruko 300 mg concentraat voor oplossing voor infusieSandoz GmbH
- PolandTyrukoSandoz GmbH
- SwedenTyruko 300 mg Koncentrat till infusionsvätska, lösningSandoz GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tyruko, Tysabri
- Liechtenstein · Tyruko, Tysabri
- Norway · Tyruko, Tysabri
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4ec7f1b2-2a23-44d3-aa48-ba4d8fb0a645 GET /v1/drugs/4ec7f1b2-2a23-44d3-aa48-ba4d8fb0a645?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "３００ｍｇ１５ｍＬ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1190402A1028",
"category": "注射薬",
"price_yen": 230345,
"generic_name": "ナタリズマブ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "1190",
"transitional_expiry": null
}See everything about ナタリズマブ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.